| Members |
targetComponentId |
| diagnostisk farvestof |
Diagnostic dye (substance) |
| Medicinal product acting as digestant (product) |
Digestant (substance) |
| diuretikum |
Diuretic (substance) |
| emetikum |
Emetic (substance) |
| blødgøringsmiddel |
Emollient (substance) |
| Medicinal product acting as fluoride supplement (product) |
Fluoride supplement (substance) |
| folsyretilskud |
Folate supplement (substance) |
| hæmostatisk middel |
Hemostatic agent (substance) |
| hypnotika |
Hypnotic agent (substance) |
| immunsupprimerende middel |
Immunosuppressant (substance) |
| Medicinal product acting as insecticide agent (product) |
Insecticide |
| Medicinal product acting as iodine supplement (product) |
Iodine supplement (substance) |
| Medicinal product acting as ion exchange resin (product) |
Ion exchange resin (substance) |
| Medicinal product acting as iron supplement (product) |
Iron supplement (substance) |
| laksantia |
Laxative (substance) |
| Medicinal product acting as loop diuretic (product) |
Loop diuretic (substance) |
| smøremiddel |
Lubricant |
| makromolekylær bloderstatning |
Macromolecular blood substitute (substance) |
| magnesiumtilskud |
Magnesium supplement (substance) |
| Medicinal product acting as manganese supplement (product) |
Manganese supplement (substance) |
| Mineraltilskud |
Mineral supplement (substance) |
| miotisk |
Miotic (substance) |
| Medicinal product acting as molybdenum supplement (product) |
Molybdenum supplement (substance) |
| Medicinal product acting as nicotinic acid supplement (product) |
Niacin supplement (substance) |
| Medicinal product acting as osmotic diuretic (product) |
Osmotic diuretic (substance) |
| oxytoksisk præparat |
Oxytocic agent (substance) |
| Medicinal product acting as pantothenic acid supplement (product) |
Pantothenic acid supplement (substance) |
| pediculicid |
Insecticide |
| Medicinal product acting as phosphorus supplement (product) |
Phosphorus supplement |
| kaliumtilskud |
Potassium supplement (substance) |
| kaliumbesparende diuretikum |
Potassium-sparing diuretic (substance) |
| Medicinal product acting as pyridoxine supplement (product) |
Vitamin B6 supplement (substance) |
| Medicinal product acting as retinol supplement (product) |
Vitamin A supplement (substance) |
| Medicinal product acting as riboflavin supplement (product) |
Riboflavin supplement (substance) |
| saluretisk lægemiddel |
Diuretic (substance) |
| Medicinal product acting as scabicide agent (product) |
Scabicide |
| sedativum |
Sedative (substance) |
| Medicinal product acting as selenium supplement (product) |
Selenium supplement (substance) |
| Natrium som kosttilskud |
Sodium supplement (substance) |
| Medicinal product acting as sulfur supplement (product) |
Sulfur supplement (substance) |
| Medicinal product acting as thiamine supplement (product) |
Thiamine supplement |
| trombolysemiddel |
Thrombolytic agent (substance) |
| uricosurikon |
Uricosuric agent (substance) |
| vasokonstriktor |
Vasopressor |
| vasodilaterende middel |
Vasodilator (substance) |
| Medicinal product acting as vasopressor (product) |
Vasopressor |
| Vitamintilskud |
Vitamin supplement (substance) |
| Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
| medroxyprogesteronacetat 104 mg injektionsvæske, suspension i fyldt injektionssprøjte a 0,65 ml |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
| Medullary carcinoma with amyloid stroma |
Medullary carcinoma with amyloid stroma |
| Medulloblastom |
Medulloblastoma |
| Mefloquine hydrochloride 250mg tablet |
Product containing precisely mefloquine (as mefloquine hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Megaconial myopathy |
A rare genetic, skeletal muscle disease with characteristics of early-onset hypotonia, muscle weakness, global developmental delay with intellectual disability and cardiomyopathy. Congenital structural heart defects and ichthyosiform cutaneous lesions have also been associated. Muscle biopsy shows characteristic enlarged mitochondria located at the periphery of muscle fibres. |
| Megakaryoblast |
Megakaryoblast |
| Megakaryocyte |
Megakaryocyte |
| Megaloblastic anaemia NOS |
Megaloblastic anemia |
| Megaloblastic anemia NOS |
Megaloblastic anemia |
| Megarectum |
Acquired megacolon |
| Meglumin iotroxinate |
Product containing iotroxic acid (medicinal product) |
| megluminiothalamat 60% infusionsvæske, opløsning, hætteglas |
Iothalamate only product |
| naevus melanocyticus iht. kategori |
Pigmented nevus |
| klinisk melanoma in situ specificeret iht. anatomisk lokalisation |
Melanoma in situ |
| melanomavaccine |
Vaccine product |
| Melanoma vaccine |
Vaccine product |
| Melanoma: [skin] or [malignant] |
Malignant melanoma |
| Melanoma: [skin] or [malignant] |
Malignant melanoma |
| melanotisk neuroektodermal tumor i spædbarnsalderen |
Melanotic neuroectodermal tumor of infancy |
| Melasian type |
Melasian type |
| memantin 2 mg/ml oral opløsning |
Memantine hydrochloride 2 mg/mL oral solution |
| Member of self-help group NOS |
Member of self-help group |
| Member of self-help group NOS |
Member of self-help group |
| Membrane metallo-endopeptidase |
Lymphocyte antigen CD10 |
| Memory disturbance (& amnesia (& symptom)) |
Memory impairment (finding) |
| Memory impairment |
Memory impairment (finding) |
| meningealt neoplasme, usikkert om benignt eller malignt |
Meningioma of uncertain behavior (morphologic abnormality) |
| meningeom |
Benign meningioma |
| Meningococcal antibody |
Neisseria meningitidis antibody |
| bivirkning af meningokokpolysaccaridvaccine |
Adverse reaction to meningococcal vaccine |
| Meniscus derangement NOS |
Derangement of meniscus |
| derangement i menisk, ikke nærmere specificeret |
Derangement of meniscus |
| Menopausal &/or postmenopausal disorders |
Disorder associated with menstruation AND/OR menopause |
| Menopausal and postmenopausal disorders |
Disorder associated with menstruation AND/OR menopause |
| menopausale og postmenopausale forstyrrelser |
Disorder associated with menstruation AND/OR menopause |
| Menopause monitoring NOS |
Menopause monitoring |
| Menopause monitoring NOS |
Menopause monitoring |
| Menstrual data NOS |
Menstrual data |
| Menstrual data NOS |
Menstrual data |
| Menstrual molimen |
Premenstrual tension syndrome |
| Menstruation disorder NOS |
Disorder of menstruation (disorder) |
| Menstruation disorder NOS |
Disorder of menstruation (disorder) |
| Menstruation disorder NOS |
Disorder of menstruation (disorder) |
| Mental &/or developmental handicap screen |
Screening for developmental disorder (procedure) |
| Mental &/or developmental handicap screen |
Screening for developmental disorder (procedure) |
| Mental Health Act examination NOS |
Mental Health Act examination |
| Undersøgelse i henhold til Mental Health Act, ikke nærmere specificeret |
Mental Health Act examination |
| psykisk lidelse – uspecificeret om under graviditet eller i puerperiet |
Mental disorders during pregnancy, childbirth and the puerperium |
| psykisk lidelse under graviditet, fødsel eller i puerperiet, ikke nærmere specificeret |
Mental disorders during pregnancy, childbirth and the puerperium |
| Mental disorders NOS |
Mental disorder |
| mentale forstyrrelser, ikke nærmere specificeret |
Mental disorder |
| Mental disorders NOS |
Mental disorder |
| Mental disorders NOS |
Mental disorder |
FHIR